{
    "2019-04-09": [
        [
            {
                "time": "2018-04-10",
                "original_text": "A股头条之上市公司公告精选（4.10）",
                "features": {
                    "keywords": [
                        "上市公司",
                        "公告",
                        "精选"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "侃财丨泡沫的虚火，减持来浇灭",
                "features": {
                    "keywords": [
                        "泡沫",
                        "减持"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "公告精选：多家券商3月业绩环比大增；吉比特拟10派100元；同花顺多名股东拟合计减持不超7.76%股份",
                "features": {
                    "keywords": [
                        "券商",
                        "业绩",
                        "环比大增",
                        "吉比特",
                        "分红",
                        "同花顺",
                        "减持"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-09",
                "original_text": "4月9日晚间上市公司十大重磅公告",
                "features": {
                    "keywords": [
                        "上市公司",
                        "重磅公告"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "百亿吸入剂市场，破除外企垄断，国内企业开始逐步突破",
                "features": {
                    "keywords": [
                        "吸入剂",
                        "外企垄断",
                        "国内企业",
                        "突破"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "恒瑞医药(600276.SH)获卡瑞利珠单抗临床试验通知书",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "卡瑞利珠单抗",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "灵康药业(603669.SH)盐酸托烷司琼注射液获批注册",
                "features": {
                    "keywords": [
                        "灵康药业",
                        "盐酸托烷司琼注射液",
                        "获批注册"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "【天风医药】迈克生物：Q1归母净利润实际增长20-30%，产品结构不断丰富",
                "features": {
                    "keywords": [
                        "迈克生物",
                        "归母净利润",
                        "增长",
                        "产品结构"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "医疗保健：创新药产业链与医疗设备及偏消费药品三大投资方向 荐14股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "创新药",
                        "医疗设备",
                        "消费药品",
                        "投资方向"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "医疗保健：居民医药消费需求依旧刚性 荐6股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "居民",
                        "医药消费",
                        "刚性需求"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "医疗保健：集采总结经验 荐7股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "集采",
                        "经验总结"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "一纸政策撬动医药大变局！“A股药王”恒瑞隐忧浮现？",
                "features": {
                    "keywords": [
                        "政策",
                        "医药",
                        "变局",
                        "恒瑞",
                        "隐忧"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "秘诀！熬出大牛股，A股史上百倍牛股的成长逻辑！",
                "features": {
                    "keywords": [
                        "牛股",
                        "成长逻辑"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "197只个股获10家及以上机构推荐 四行业成A股战略布局要塞",
                "features": {
                    "keywords": [
                        "个股",
                        "机构推荐",
                        "战略布局",
                        "行业"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}